Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Business Update

31 May 2011 07:00

RNS Number : 4905H
Regenersis PLC
31 May 2011
 



 

31 May 2011

 

Regenersis plc

 

("Regenersis" or the "Group")

 

Business Update

 

 

Regenersis, a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to provide an update on progress. It is anticipated that the outcome of the ongoing operational and strategic review, which commenced in March, will be shared with investors before the end of this financial year in June. Today, the Group is able to announce several specific actions and changes.

 

Organisation Changes

 

Our recent activity as a Group has been designed to ensure that our efforts focus on markets where we are able to differentiate our services, create competitive barriers and deliver sustainable growth in revenues and margins. We are moving rapidly to implement a new organisation structure which supports this intent, including a global sales force and new reporting and incentive structures, and we have made several key senior appointments in recent months.

 

Ian Powell has joined the Group as Group Managing Director reporting to the Executive Chairman. Ian has a long and successful track record in driving significant operational and profit improvement in complex, multi-geography businesses. Most recently he delivered a step change in profitability as CEO of Chapelthorpe Plc, a fibres manufacturing business with factories in the UK, Austria, Russia and the USA. Prior to that he ran the UK operations of 4imprint plc.

 

Sergio Tansini, previously Managing Director of our Mobile division has taken on a new role as Group Sales Director. Winning and expanding large, multi-geography accounts is critical to boosting growth across the Group and Sergio will spearhead this activity, reporting directly to the Executive Chairman.

 

Andrew Lee has been appointed as Managing Director of the UK Mobile businesses. His previous roles include Managing Director of Dataforce Group (marketing and logistics), Group Operations Director of N Brown Group plc (catalogue retailer), and Managing Director of Demand Chain Logistics at the Unipart Group. Andy is currently a non-executive Director of the Group and will step down from this role in order to pick up these executive responsibilities. He will be replaced in due course by a new independent non-executive Director.

 

Head Office Relocation

 

The Board has reduced the size of the Group central team and relocated the Group functions to our existing facility in Huntingdon. Jeremy Wilson the Chief Financial Officer continues in his role, reporting to the Executive Chairman. Central Costs in the next financial year are expected to be around £0.9 million lower than the £2.7 million in the last reported financial year.

 

Contracts

 

After a protracted period of negotiation stretching back to 2010 the Group has not been successful in renewing its contract with Hutchison 3G UK. The Board anticipates that this effect will not impact expectations for the current financial year and, furthermore, we believe that any impact in the next financial year to June 2012 will be more than outweighed by factors including the contribution of new business recently won or at an advanced stage of negotiation.

 

Banking

 

The Board is pleased to report that it has secured a £15m banking facility with HSBC until October 2015, replacing the Group's previous banking arrangements and providing a good platform for growth.

 

 

Matthew Peacock, Executive Chairman of Regenersis commented:

 

"I am encouraged by the early strategic progress we have made since March. We have brought new skills in to the senior team, increasingly focused our efforts on differentiating our services and undertaken further work to fine-tune the Regenersis offer. This work continues and I look forward to presenting a fuller account of our strategic plans in June."

 

 

Enquiries:

 

Regenersis plc

+44 (0) 1865 471 900

Matthew Peacock / Jeremy Wilson

 

 

 

Arden Partners plc

+44 (0) 121 423 8900

Steve Douglas

 

 

 

Financial Dynamics

+44 (0) 20 7831 3113

Matt Dixon / Charles Palmer

 

 

 

 

Ends

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXSXAFSFEFF
Date   Source Headline
4th Oct 20185:41 pmRNSHolding(s) in Company
25th Sep 20187:00 amRNSFinal Results
27th Jul 20189:14 amRNSHolding(s) in Company
26th Jul 201811:00 amRNSDirector/PDMR Shareholding
11th Jul 20187:00 amRNSAppointment of Chief Financial Officer
11th Jul 20187:00 amRNSTrading Update and Notice of Results
29th Jun 20188:59 amRNSHolding(s) in Company
13th Jun 201812:16 pmRNSHolding(s) in Company
12th Jun 201812:28 pmRNSHolding(s) in Company
18th Apr 20182:40 pmRNSHolding(s) in Company
18th Apr 201812:05 pmRNSHolding(s) in Company
29th Mar 201811:40 amRNSDirector/PDMR Shareholding
28th Mar 20187:00 amRNSAppointment of Chief Executive Officer
26th Mar 201812:04 pmRNSHolding(s) in Company
22nd Mar 20182:27 pmRNSHolding(s) in Company
20th Mar 20187:11 amRNSHalf-year Report
9th Feb 201812:31 pmRNSDirector/PDMR Shareholding
19th Jan 201810:27 amRNSHolding(s) in Company
19th Jan 20187:00 amRNSTrading Update and Notice of Results
19th Dec 20175:35 pmRNSResult of AGM
24th Nov 20172:48 pmRNSPosting of Annual Report & Notice of AGM
8th Nov 20172:05 pmRNSSecond Price Monitoring Extn
8th Nov 20172:00 pmRNSPrice Monitoring Extension
7th Nov 20177:00 amRNSFinal Results
6th Nov 201710:25 amRNSHolding(s) in Company
3rd Nov 20175:03 pmRNSNotice of Results
13th Oct 20171:01 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreparation of preliminary results
27th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 20175:54 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSBoard Update
4th Sep 20177:00 amRNSUpdates on revenue and management
3rd Aug 201712:37 pmRNSHolding(s) in Company
11th Jul 20173:33 pmRNSHolding(s) in Company
6th Jul 20177:00 amRNSTrading Statement
6th Jun 20173:16 pmRNSHolding(s) in Company
30th May 20177:00 amRNSDirectorate Change
16th May 20177:00 amRNSUpdate on Ordinary Shares
12th May 20173:53 pmRNSHolding(s) in Company
10th May 20173:34 pmRNSDirector/PDMR Shareholding
9th May 201712:27 pmRNSDirector/PDMR Shareholding
9th May 201712:26 pmRNSHolding(s) in Company
4th May 20177:00 amRNSResult of Placing
3rd May 20175:04 pmRNSProposed Placing
26th Apr 20176:01 pmRNSHolding(s) in Company
25th Apr 20177:00 amRNSQ3 Trading Update, Cash Flow Review and Funding
15th Mar 20172:55 pmRNSHolding(s) in Company
15th Mar 201711:27 amRNSDirector/PDMR Shareholding
15th Mar 20177:00 amRNSDirector/PDMR Shareholding
14th Mar 20172:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.